225 related articles for article (PubMed ID: 20508255)
21. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis.
Lin CL; Bristol LA; Jin L; Dykes-Hoberg M; Crawford T; Clawson L; Rothstein JD
Neuron; 1998 Mar; 20(3):589-602. PubMed ID: 9539131
[TBL] [Abstract][Full Text] [Related]
22. Astrocytic transcription factor REST upregulates glutamate transporter EAAT2, protecting dopaminergic neurons from manganese-induced excitotoxicity.
Pajarillo E; Digman A; Nyarko-Danquah I; Son DS; Soliman KFA; Aschner M; Lee E
J Biol Chem; 2021 Dec; 297(6):101372. PubMed ID: 34756885
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120.
Wang Z; Pekarskaya O; Bencheikh M; Chao W; Gelbard HA; Ghorpade A; Rothstein JD; Volsky DJ
Virology; 2003 Jul; 312(1):60-73. PubMed ID: 12890621
[TBL] [Abstract][Full Text] [Related]
24. Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2).
Su ZZ; Leszczyniecka M; Kang DC; Sarkar D; Chao W; Volsky DJ; Fisher PB
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1955-60. PubMed ID: 12578975
[TBL] [Abstract][Full Text] [Related]
25. A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases.
Fontana IC; Souza DG; Souza DO; Gee A; Zimmer ER; Bongarzone S
J Med Chem; 2023 Feb; 66(4):2330-2346. PubMed ID: 36787643
[TBL] [Abstract][Full Text] [Related]
26. Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2.
Kato T; Kusakizako T; Jin C; Zhou X; Ohgaki R; Quan L; Xu M; Okuda S; Kobayashi K; Yamashita K; Nishizawa T; Kanai Y; Nureki O
Nat Commun; 2022 Aug; 13(1):4714. PubMed ID: 35953475
[TBL] [Abstract][Full Text] [Related]
27. An association between genotypic variations and protein expression of the glial glutamate transporter 2 in the human nucleus accumbens.
Kerdsan W; Thanoi S; Nudmamud-Thanoi S; Reynolds GP
Neurosci Lett; 2012 Aug; 523(2):108-10. PubMed ID: 22750157
[TBL] [Abstract][Full Text] [Related]
28. Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.
Takahashi K; Foster JB; Lin CL
Cell Mol Life Sci; 2015 Sep; 72(18):3489-506. PubMed ID: 26033496
[TBL] [Abstract][Full Text] [Related]
29. Glutamate induced neonatal excitotoxicity modifies the expression level of EAAT1 (GLAST) and EAAT2 (GLT-1) proteins in various brain regions of the adult rat.
Castañeda-Cabral JL; López-Ortega JG; Fajardo-Fregoso BF; Beas-Zárate C; Ureña-Guerrero ME
Neurosci Lett; 2020 Sep; 735():135237. PubMed ID: 32645399
[TBL] [Abstract][Full Text] [Related]
30. Endothelins negatively regulate glial glutamate transporter expression.
Rozyczka J; Figiel M; Engele J
Brain Pathol; 2004 Oct; 14(4):406-14. PubMed ID: 15605988
[TBL] [Abstract][Full Text] [Related]
31. β-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes.
Lutgen V; Narasipura SD; Sharma A; Min S; Al-Harthi L
J Neuroinflammation; 2016 Sep; 13(1):242. PubMed ID: 27612942
[TBL] [Abstract][Full Text] [Related]
32. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
[TBL] [Abstract][Full Text] [Related]
33. Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus.
Kong Q; Takahashi K; Schulte D; Stouffer N; Lin Y; Lin CL
Neurobiol Dis; 2012 Aug; 47(2):145-54. PubMed ID: 22513140
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1.
Yang Y; Gozen O; Vidensky S; Robinson MB; Rothstein JD
Glia; 2010 Feb; 58(3):277-86. PubMed ID: 19672971
[TBL] [Abstract][Full Text] [Related]
35. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis.
Flowers JM; Powell JF; Leigh PN; Andersen P; Shaw CE
Ann Neurol; 2001 May; 49(5):643-9. PubMed ID: 11357955
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of 5' splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid.
Münch C; Zhu BG; Leven A; Stamm S; Einkörn H; Schwalenstöcker B; Ludolph AC; Riepe MW; Meyer T
J Neurosci Res; 2003 Mar; 71(6):819-25. PubMed ID: 12605408
[TBL] [Abstract][Full Text] [Related]
37. The glutamate transporter EAAT2 is transiently expressed in developing human cerebral white matter.
Desilva TM; Kinney HC; Borenstein NS; Trachtenberg FL; Irwin N; Volpe JJ; Rosenberg PA
J Comp Neurol; 2007 Apr; 501(6):879-90. PubMed ID: 17311320
[TBL] [Abstract][Full Text] [Related]
38. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2.
Boston-Howes W; Gibb SL; Williams EO; Pasinelli P; Brown RH; Trotti D
J Biol Chem; 2006 May; 281(20):14076-84. PubMed ID: 16567804
[TBL] [Abstract][Full Text] [Related]
39. Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2.
Hoogland G; Bos IW; Kupper F; van Willigen G; Spierenburg HA; van Nieuwenhuizen O; de Graan PN
Neurochem Int; 2005 Dec; 47(7):499-506. PubMed ID: 16137792
[TBL] [Abstract][Full Text] [Related]
40. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.
Sheldon AL; Robinson MB
Neurochem Int; 2007; 51(6-7):333-55. PubMed ID: 17517448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
